For instance, the split FLuc methodology was used in cell culture models as well as in tumor xenograft models of breast cancer (see Section 8) to measure changes in chemokine receptor CXCR4 (and CXCR7) homodimerization in response to pharmacological agents [98]. The gene discussed is ACKR3; the disease is neoplasm.